Correlating Cardiac Action Potentials with Metabolic Markers during Acute Cardiac Ischemia in Rabbit Hearts by Kimball, Jeremiah
CORRELATING CARDIAC ACTION POTENTIALS WITH METABOLIC 
MARKERS DURING ACUTE CARDIAC ISCHEMIA IN RABBIT HEARTS 
 
by 
Jeremiah Kimball 
 
A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Master of Science in the 
Department of Biomedical Engineering. 
 
Chapel Hill 
2006 
 
Approved by 
 
Advisor: Dr. Stephen B. Knisley 
 
Reader: Dr. Jeffrey Macdonald 
 
Reader: Dr. Caterina Gallippi 
 
ii
 
ABSTRACT 
 
JEREMIAH KIMBALL: Correlating Cardiac Action Potentials with Metabolic Markers 
during Acute Cardiac Ischemia in Rabbit Hearts 
(Under the direction of Stephen B. Knisley, Ph.D.) 
 
We have developed the first system, to our knowledge, that simultaneously 
measures 31P nuclear magnetic resonance (NMR) and optical action potentials (APs) in 
order to determine the dynamic relationship between certain metabolic markers and AP 
morphology during acute ischemia in rabbit hearts. Our system utilizes a ratiometric 
optical technique with transmembrane voltage-sensitive dye, di-4-ANEPPS, to measure 
APs with no pharmalogical motion inhibition. Fiber optics measure APs by passing light 
to and from the heart within an NMR magnet. 31P NMR measurements verified the 
stoichiometric relationship between inorganic phosphate and phosphocreatine; as 
phosphocreatine levels decrease, inorganic phosphate levels increase. During acute 
ischemia, intracellular pH levels remained constant and ;-ATP levels decreased 22.4%. 
Simultaneous optical measurements show reductions in AP amplitude (-83.3%) and heart 
rate (-56.6%).  AP duration increased (+875%), implicating other possible factors.  These 
findings demonstrate a real-time correlation between ischemic depletion of high-energy 
phosphagens, and decreased AP amplitude and duration. 
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CHAPTER I 
 
INTRODUCTION 
 
31P nuclear magnetic resonance spectroscopy (NMR) has long been shown 
effective in measuring the concentrations of key high energy phosphate compounds 
involved in cardiac metabolism (Gadian DG et. al. 1976; Marsden PK et. al. 2000; Honda 
H et. al. 2002). By collecting time-resolved 31P NMR spectra, changes in these metabolic 
marker concentrations can be analyzed through time. Cardiac ischemia, the blockage or 
constriction of coronary arteries, has frequently been the subject of such studies. 
Simultaneous measurement of metabolic marker concentrations with cardiac 
transmembrane action potentials (APs) would allow greater insight into possible 
mechanisms behind changes in AP morphology during cardiac ischemia. 
Early measurements of cardiac APs utilized microelectrodes, however, these 
systems incorporate metal components that might interfere with NMR spectroscopy 
measurements or vice-versa. With the development of a ratiometric optical technique for 
measuring cardiac APs with no pharmalogical motion inhibition, simultaneous 
measurement of cardiac APs and metabolic marker levels is possible. Dual modality 
systems have been utilized for decades to correlate different functional aspects of cardiac 
dysfunction (Tamura, H et al. 1988; Tamura, H et al. 1989; Kupriyanov, D et al. 2000; 
Marsden, S et al. 2002).  No other technique is known to simultaneously utilize 31P NMR 
and optical AP recordings with ratiometry to correlate high energy phosphagen levels and 
2transmembrane potentials in the heart.  The potential benefits for a real-time system for 
imaging biochemical activity within the heart seem applicable to some forms of heart 
disease. 
Prior to this thesis, the novel dual modality system to simultaneously measure 
cardiac APs and high energy metabolites was fabricated. This thesis concerns the 
optimization of that system and utilizing it to determine the dynamic relationship between 
AP morphology and certain metabolic marker levels during acute ischemia. Five high 
energy metabolites were observed over the time course of these measurements including 
pH, sugar phosphates, phosphocreatine, phospholipid intermediates, and ATP. This novel 
system and the important information it provides will join on-going research to determine 
the effects of cardiac ischemia and how ischemia can lead to an increased defibrillation 
threshold and arrhythmias. 
 
CHAPTER II 
 
BACKGROUND 
 
2.1 Overview
Cardiac arrest is the sudden loss of cardiac function resulting from the cessation 
of all rhythmical impulses in the heart (Guyton AC and Hall JE 2000).  Even though it is 
currently the focus of a substantial amount of research, the mechanisms behind what 
causes cardiac arrest are not completely understood.  Initial symptoms may include chest 
pains, but late stages without treatment irrevocably lead to unconsciousness, loss of pulse 
and respiration, and death.  A common cause of cardiac arrest is ventricular fibrillation 
(VF) (Zipes DP and Jalife J 2000). In VF, sudden rapid, erratic electrical activity in the 
ventricles of the heart leads to the loss of coordinated contractions of the heart.  
Heartbeats are rapid and inefficient leading to the cessation of blood circulation in the 
body.  Cardiac ischemia, the lack of oxygenated blood flow to myocardial tissues, often 
leads to arrhythmias such as VF (Penny, W.J. et al. 1983). Therefore, understanding the 
effects of cardiac ischemia, how they lead to VF and the development of treatment 
methods, is a very important area of research. 
2.2 Cardiac Ischemia and Its Effects on Action Potentials and Metabolism
Cardiac ischemia is caused by the blockage or constriction of coronary arteries. 
This reduction in oxygenated blood flow to myocardial tissue can cause irreversible 
damage to the heart if prolonged. Reperfusion, the return of oxygenated blood flow, 
4might seem like the end solution to acute cardiac ischemia; however, even reperfusion 
can cause more injury to the heart (Braunwald E. et. al. 1985).  
Cardiac muscle contractions are the result of rhythmic, coordinated electrical 
activity.  Electrical stimulation of cardiac muscle usually begins at the sinoatrial node, the 
impulse generating (pacemaker) tissue located in the right atrium of the heart.  This 
electrical impulse, or action potential (AP), propagates throughout the heart via a 
specialized conduction system.  APs serve to stimulate the excitatory and conductive 
muscle fibers of the heart to induce contractions.  APs begin with rapid changes in 
membrane potential, usually from resting level between -80 mv and -90 mv, then 
becoming positive 40mv.  The threshold for sodium current activation during the 
beginning of an AP is generally considered to be approximately -65 mv (Zipes DP and 
Jalife J 2000).  Figure 2.1 illustrates the simplified shape of an AP generated by a 
ventricular cardiac myocytes. 
Figure 2.1.  Simplified Ventricular Cardiac Myocyte AP. 
The cardiac AP has five sections or phases.  Phase 4 represents resting membrane 
potential.  Phase 0, the upstroke, represents rapid depolarization; this results in the 
5opening of some voltage-gated Na+ channels, the rapid influx of Na+, and further 
depolarization.   This causes the remainder of the voltage gated Na+ channels to open and 
further depolarization.  Phase 1 begins once a membrane potential of approximately +40 
mv is reached.  At this point, the voltage-gated Na+ channels become inactivated; 
simultaneously, voltage-gated potassium channels begin to open, causing a slight 
repolarization.  During phase 2, the plateau, L-type (“long-lasting”) voltage-gated Ca2+ 
channels open creating a momentary balance between Ca2+ influx and K+ efflux.  Phase 3 
represents the inactivation of the L-type Ca2+ channels and continued efflux of K+,
repolarizing the cell.  Voltage-gated K+ channels become inactivated around -45 mv, but 
K+ efflux continues through K+ leakage channels until resting membrane potential is 
reached (Guyton, A. C. et. al. 2000). 
During ischemia, the ion concentrations of cardiac myocytes (cardiac muscle 
cells) change. Extracellular potassium concentrations increases as a result of three 
factors: ATP-dependent K+ channel activation causing an efflux of potassium (Taniguchi, 
J. et. al. 1983), a reduction in Na+-K+ pump activity causing a decrease in K+ influx 
(Weiss, J., et. al. 1986), and a decrease in extracellular space due to the increase in 
osmotically active particles inside the cell (Tranum-Jensen, J. et. al. 1981). Intracellular 
sodium concentrations typically increase as a result of passive inward leakage and 
reduced active efflux (Carmeliet, Edward. 1999). This may be a partial result of an 
increase in intracellular magnesium ions, due to accelerated ATP hydrolysis, which block 
sodium efflux from Na+/Mg2+ channels (De Weer, P. 1976).  Intracellular calcium tends 
to increase and “overload” during cardiac ischemia due to four factors: less efficient 
removal to the extracellular space, reduced sarcoplasmic reticulum (SR) uptake, 
6increased inward leak, and displacement by H+ from binding sites (Peuhkurinen, K. J. 
2000).  Increased calcium overload can cause spontaneous calcium release in the absence 
of trigger Ca2+. The result can be early afterdepolarizations (EAD) and/or delayed 
afterdepolarizations (DAD) (Luo, Ching-Hsing. et al. 1994). 
 These changes in ion concentrations seem to be a major factor behind changes in 
AP morphology.  Acute ischemia results in a depolarization from the normal resting 
membrane potential, producing a transient increase in excitability.  Depending on the 
extent of further depolarization, fast Na+ current is either partially or completely 
inhibited.  This, along with the rise in extracellular potassium, leads to the depression of 
AP amplitude and upstroke velocity (Carmeliet, Edward. 1999; Coronel, R. et al. 1989). 
AP duration is initially prolonged, but begins to shorten soon afterwards due partially to 
rising extracellular potassium levels (Verkerk, Arie O., Veldkamp, Marieke W., et al. 
1996).  On a larger scale, theses changes tend to cause a decrease in heart rate as 
ischemia progresses.  Most of the normal AP morphological features recover during 
reperfusion after acute ischemia; however, coronary vascular injury and the no-reflow 
phenomenon due to oxygen radical stress can cause abnormal AP morphology during 
reperfusion, especially concerning AP duration (Aiello, Ernesto A. et al. 1995). 
 Ischemia also causes major disturbances in myocardial metabolism. High-energy 
phosphate metabolite levels experience abnormal fluctuations due to the lack of 
oxygenated blood flow. Any oxygen remaining in the system is consumed by oxidative 
phosphorylation. Phosphocreatine (PCr) stores are consumed to maintain a steady 
production of ATP, the body’s principal source of energy; however these reserves are not 
limitless. They can become exhausted with prolonged ischemia.  Inorganic phosphate (Pi) 
7levels rise due to the consumption of ATP and the inability of the tissues to regulate 
metabolic waste accumulation. Anaerobic metabolism (glycolysis) is initiated, but can 
only help maintain ATP levels for a short period of time due limited ATP production 
efficiency and the buildup of lactic acid and hydrogen ions.  If ischemia is prolonged, 
ATP levels will begin to drop dramatically (Peuhkurinen, K. J. 2000).  Net hydrogen ion 
concentration rises due to the increased production of protons and insufficient removal 
(Dennis, S. C. et al. 1991).  Increased net hydrogen ion concentration decreases 
intracellular pH, causing acidosis.  Acidosis is known to cause a decrease in resting 
potential, depressed upstroke velocity, an increase in AP duration, and possibly EADs; 
however, prolongation of the AP and EADs are not seen during ischemia (Coraboeuf, E. 
et. al. 1980). 
2.3 Fluorescence and Ratiometry Overview
A photon is a unit or “particle” of electromagnetic radiation.  Photons have a 
unique wavelength that is inversely proportional to their energy.  Therefore, higher 
energy photons have shorter wavelengths, i.e. red light at 650 nm has more energy than 
green light at 420 nm. Fluorescence is the emission of electromagnetic radiation in which 
a molecule absorbs a high-energy photon, and re-emits it as a lower-energy photon.  
Molecules that carry fluorescent properties are called fluorophores or fluorescent dyes.  
 When a fluorophore is irradiated with a photon of light at the appropriate 
excitation wavelength, the photon is absorbed.  This process creates an excited state 
where the fluorophore undergoes certain conformational changes.  Shortly thereafter, the 
molecules excited by absorption return to their ground state, emitting a photon in the 
8process.  The photon emitted is of a lesser energy (longer wavelength) than the photon 
absorbed due to the energy loss encountered over the course of the interaction.   
 Di-4-ANEPPS is a fast, voltage-sensitive, fluorescent dye commonly used to 
detect action potentials across the membranes of cardiac muscle cells (myocytes).  Di-4-
ANEPPS is unique because its structure allows it to anchor into the membrane of a 
muscle cell.  When excited by visible light of suitable wavelength, i.e. blue laser light at 
488 nm, it emits a combination of red and green light.  However, if placed inside a 
cardiac myocyte cell membrane, it will experience a reversible shift towards shorter 
wavelengths in response to membrane depolarization (Fluhler, E. et. al. 1985).  In the 
case of excitation by blue laser light at 488 nm, depolarization will shift emission towards 
wavelengths associated with green light (510-570 nm), increasing green light intensity.  
Also advantageous is the fact that the increase in green emission during depolarization is 
directly proportional to the simultaneous decrease in red (>590 nm) emission (Johnson, 
P.L. et. al. 1999).  Figure 2.2 illustrates the reversible shift of Di-4-ANEPPS in response 
to changes in transmembrane voltage. 
 
9Figure 2.2. Shift in wavelength of Di-4-ANEPPS in response to changes in cardiac myocyte 
transmembrane voltage.  The broken line represents shift in wavelength due to depolarization. 
 
The advantage of using Di-4-ANEPPS to measure changes in cardiac myocyte 
transmembrane voltage is the ability to record both red and green emissions for the 
purpose of using their ratio to reveal the true optical action potential.  By taking the ratio 
of green to red emissions, changes in fluorescence common to both signals cancel; 
therefore, the effects of motion, photobleaching, and variations in dye concentration are 
significantly lessened (Knisley, S.B. et al. 2000).   
2.4 31P NMR Overview
Nuclear magnetic resonance spectroscopy (NMR) exploits the magnetic 
properties of certain atomic nuclei.  Certain nuclei, such as phosphorous-31 (31P), possess 
an intrinsic magnetic moment, associated with its atomic spin.  For example, if a strong, 
homogenous magnetic field, were applied to such nuclei, these tiny “magnets” would 
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align themselves along the length of the field.  NMR allows identification of individual 
atoms contained within molecules of a sample.  In 31P NMR, molecules containing 
phosphorous can be individually identified by chemical shift based on their unique 
molecular structure. 
 There are five units necessary for NMR spectroscopy: the transmitter, magnet, 
probe, receiver, and computer. The sample is placed inside the probe, centered about the 
“sweet spot,” the position of best energy propagation efficiency, of the coil of wire.  The 
coil is the main component of the probe considering it is both transmits and receives the 
radiofrequency energy necessary to produce a signal.  The probe is then placed inside the 
electromagnet that produces a strong, homogenous magnetic field, B0, about the probe.  
The transmitter then transmits a short pulse of power into the probe in the form of a 
radiofrequency (RF) magnetic field, B1, with a frequency corresponding to the resonance 
frequency.  The resonance frequency is unique and depends on the nuclei and B0. The 
coil then applies the RF pulse to the sample and the tiny “magnets,” previously aligned 
with the large B0 field, almost instantaneously align with the local B1 magnetic field.  
Once the short B1 pulse dissipates, the nuclei begin to relax back to their original 
alignment within B0. As relaxation progresses, the nuclei emit RF energy that is 
absorbed by the coil and transmitted to the receiver, where it is collected and sent to the 
computer for processing.   
 Depending on the molecular environment of each 31P nuclei within the sample, 
nuclei will produce signals with slightly different resonance frequencies.  For example, 
31P nuclei from PCr will appear at a different frequency than the 31P nuclei from ATP. 
The difference between the resonance frequencies and a standard 31P resonance 
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frequency reference is called chemical shift and can be in units of parts per million (ppm) 
or hertz (Hz).  These signals are processed by the computer and displayed in the form of 
NMR spectra.  In general, the individual heights of the peaks on NMR spectra correspond 
to the number of nuclei that contribute to them.  Examples of NMR spectra follow in the 
Results Chapter in Figure 4.3. 
 
CHAPTER III 
 
METHODS 
 
3.1 Optimization of the Dual Modality System
Before performing live rabbit heart experiments, the NMR parameters needed to 
be optimized for increased temporal resolution.  Previously, the original parameters 
dictated 10 minutes between each spectral acquisition.  In order to observe the finer 
details of rapid changes in AP morphology and high energy metabolite levels, the 
temporal resolution needed to be increased.  To do so, a new set of parameters were 
introduced (Table 3.1).   
Parameter Value 
TD 8192 
NS 64 
DS 2 
SW 56 ppm 
AQ (TD/SW) 0.5014004 sec 
D1 1.5 sec 
P1 50 µsec 
Table 3.1. 31P NMR Parameters for Maximum Temporal Resolution 
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The number of data points (TD) and sweep width (SW) were altered to produce a new, 
faster acquisition time (AQ).  The number of dummy scans (DS), the number of scans 
(NS), the relaxation time (D1), and pulse width (P1) were all reduced as well.  
Incorporating these new values provided near maximum temporal efficiency and only 2 
minutes per spectral acquisition.  All other parameters remained unaltered. 
 Along with changes to the temporal resolution, the shim set was also improved 
upon.  The shim set is what determines the homogeneity of the magnetic field 
surrounding the sample.  A better shim set will produce a better signal-to-noise ratio 
(SNR).  To imitate the general shape, size, and phosphate composition of a rabbit heart, a 
small balloon filled with a comparable concentration of phosphate buffered saline (PBS) 
was placed inside the NMR tube.  The shim set was altered by observing changes in the 
shape of the free induction decay (FID) during a continuous acquisition.  Once a potential 
shim set was produced, spectra were acquired and the SNR was determined.  The shim 
set that produced the best SNR was used during the live rabbit experiments. 
3.2 Heart Preparation
Hearts were excised rapidly from pentobarbital-anesthetized New Zealand White 
rabbits in accordance with Institutional Animal Care and Use Committee guidelines. A 
cannula including a fiber optic was immediately placed into the aorta with the fiber tip 
positioned in the left ventricle. The hearts were Langendorff-perfused to flush the blood 
from the vessels and oxygenate the myocardium. Figure 3.1 illustrates the perfusion 
apparatus and the components used such as the pump, filter, bubble trap, fiber optic, 
NMR magnet, etc. 
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Figure 3.1. Diagram of the perfusion apparatus used in rabbits experiments. 
The Tyrode solution perfusate was composed of the following (in mM): 129 
NaCl, 5.4 KC1, 1.8 CaCl2, 1.1 MgCl2, 26 NaHCO3, 1 Na2HPO4, and 11 glucose.  The 
solution was equilibrated to 95% O2 and 5% CO2 with gas exchangers fabricated from 
silicone tubing. The hearts were placed in a standard 28-mm glass NMR tube with inflow 
and outflow tubes.  The perfusate was delivered at a flow rate of 23 ml/min and at room 
temperature (23.5 ºC) during all experiments. The outflow tube removed residual 
perfusate at a flow rate of 27 ml/min to avoid overflowing of the NMR tube. Throughout 
the procedure, the hearts were perfused with physiological saline except when attempting 
to induce ischemia.  Hearts were stained with a stock solution of Di-4-ANEPPS (5mg Di-
4-ANEPPS dissolved in 3mL of DMSO). The dye was loaded, by bolus injection of 0.4 
ml stock solution, through the tubing above the aorta.   
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3.3 31P NMR and Optical Fluorescence Measurements
To record 31P NMR spectra, the NMR tube was placed in a glass cradle of a 
custom-built 31P NMR probe. Beforehand, the heart was positioned in the NMR tube to 
be aligned with the sweet spot of the 31P Helmholtz coil, i.e. the spot where the sensitivity 
of NMR signal was greatest.  The probe was placed in a Bruker Avance 360 MHz NMR 
spectrometer (80 mm vertical bore), and tuned and matched to 145.8 MHz, the 31P
resonance frequency. The field value and shim set remained consistent throughout the 
experiments.  Spectra were acquired every 2 minutes by averaging 64 transients, each 
with 2 second duration.  
To simultaneously record transmembrane APs, a custom optical fluorescence 
emission measurement system was used (Figure 3.2). Hearts were excited with blue 
argon laser light (488 nm) that passed through a fiber optic and was transferred to another 
fiber optic using a blue dichroic mirror. The light then passed through the fiber optic that 
was inserted into the aortic cannula of the perfusion system and into the left ventricle, 
exciting the fluorescent dye in ventricular endocardium. Emitted fluorescence from the 
heart was collected with the same fiber optic that delivered the excitation light. The light 
passed through filters, to separate the red and green fluorescence, and was collected by 
two photomultiplier tubes (PMTs).  PMTs are extremely sensitive detectors of light.  
They take incident light photons, generate electrons by the photoelectric effect, and 
accelerate them through an electric field while contacting several dynodes.  Upon striking 
each dynode, low energy electrons are released and progress towards the next dynode.   
PMTs output a voltage proportional to the number of initial photons.  The gain can be 
adjusted by altering the dynode voltage.  The PMTs produced two waveforms, red and 
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green, on an oscilloscope.  Each of these represents the motion and action potentials 
produced by the heart.  The ratio of the red and green signals from the PMTs was used to 
reveal APs without motion artifacts.  Optical recordings of the APs were taken every 2 
minutes, approximately 1 minute into each NMR spectral acquisition.  Optical APs were 
observed and saved on an oscilloscope; NMR data were saved on the Bruker. 
Figure 3.2. Optical recording system for ratiometric measurements in rabbit hearts stained with 
transmembrane voltage-sensitive fluorescent dye di-4-ANEPPS. 
Simultaneous 31P NMR and optical fluorescence measurements were first taken 
for 20 minutes during pre-ischemia/control. Ischemia was induced by interrupting the 
aortic perfusion at 20 minutes. Approximately half of the experiments maintained 
ischemic conditions for 10 minutes and the other half for 20 minutes. In all experiments, 
17
reperfusion occurred directly after ischemia and measurements were taken for an 
additional 30 minutes. 
 
CHAPTER IV 
 
RESULTS 
 
4.1 Overview
A total of five live rabbit experiments were completed over a 6 month period.  
However, due to the complexity of the dual modality system, only two of those 
experiments produced viable, simultaneous optical and 31P NMR data.  These two 
experiments were completed on August 2nd, 2005 and September 26th, 2005; henceforth, 
these two experiments will be designated as “Run #1” and “Run #2,” respectively.  Both 
runs produced data in both modalities, however, Run #1 did not show any optical APs 
beyond the first control recording (as seen in Figure 4.1). 
4.2 Optical Recordings in Control, Ischemia, and Reperfusion
Figure 4.1 shows ratiometric optical recordings of the APs during pre-ischemia of 
Run #1 and at key points during Run #2.  Run #1 produced an excellent example of a 
control AP; however possible equipment malfunction reduced the remainder of the AP 
recordings to noise.  Run #2 produced recordings that more closely resembled the 
morphology of an AP.  (The viability of these recordings will be discussed further in the 
next chapter.)  Run #1 recordings were taken with a ten second length while Run #2 
recordings were taken with a four second length.  The reduction in the length of recording 
was done to reduce save time.  All optical recordings were also filtered with a 5 ms 
boxcar filter to eliminate high frequency noise.  
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Fig 4.1. Ratiometric fluorescence recordings of action potentials (A) during pre-ischemia of Run #1 and 
(B) at key points during Run #2. Emission ratiometry techniques were used to produce the true action 
potential.  A 5 ms boxcar filter was used. A boxcar filter is a digital FIR filter and thus has linear phase. 
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Figure 4.1 shows AP recordings at the onset of ischemia (approximately one 
minute into ischemia), at various points during ischemia, and approximately 15 minutes 
after reperfusion.   
A boxcar filter is a digital FIR filter and thus has linear phase.  Figure 4.2 shows 
the implementation of the boxcar filter and how it produces no phase change in the 
filtered result. 
Figure 4.2. Implementation of the 5ms boxcar filter. Comparing the unfiltered ratio with its filtered 
counterpart, it can be seen that there is no phase shift due to the implementation of the boxcar filter. 
 
Matlab was utilized to calculate standard aspects of AP morphology.  Values for 
AP amplitude (APA), AP duration at 50% amplitude (APD50%), and beats per minute 
(BPM) were calculated through graphical interpretation.  APA was determined by 
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subtracting the baseline ratio value from the maximum value at the AP peak.  APD50% 
was calculated by subtracting the time from time at half the repolarization amplitude.  
BPM was determined by extrapolation from the number of APs that occurred during the 
four second period.  A summary of these values are contained in Table 4.1. 
Time APA (unitless) APD50% (sec) BPM (min-1)
22 minutes 
(Onset of Ischemia) 
0.3 0.25 45 
24 minutes 
(Ischemia) 
0.2 0.308 40 
26 minutes 
(Ischemia) 
0.1 0.46 38 
28 minutes 
(Ischemia) 
0.08 1.85 24 
30 minutes 
(Ischemia) 
0.07 2 21 
32 minutes 
(Ischemia) 
0.09 >2 19.53 
34 minutes 
(Ischemia) 
0.07 >2 <19.53 
36 minutes 
(Ischemia) 
0.05 >2 <19.53 
38 minutes 
(Ischemia) 
0.05 >2 <19.53 
40 minutes 
(Ischemia) 
No  
Data 
No  
Data 
No  
Data 
66 minutes 
(Reperfusion) 
0.4 .38 40.05 
Table 4.1. Optical Action Potential Analysis for Run #2. 
At the time of ischemia (T=20min-40min), optical measurements show an overall 
reduction in APA by 83.3%, an increase in APD50% by 875%, and reduction in intrinsic 
heart rate by 56.6% (Table 4.1).  Ischemic recordings continued to follow this trend until 
perfusion was reinstated.  Due to the increasing duration of the AP after 32 minutes and 
the short, four second recording period, it became impossible to determine the APD50% 
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and BPM.  No optical data was collected for ischemia at the 40 minute mark due to 
equipment error. 
 
4.3 31P NRM Spectroscopy Recordings in Control, Ischemia, and Reperfusion
Spectra were comprised of five phosphate peaks representing phosphocreatine, 
ATP (U, ;, and V), inorganic phosphate, and phosphomonoester (the latter two are usually 
interpreted as one peak). Once acquired, the spectra were adjusted by zero-order phasing 
(PH0) and automatic baseline subtraction (ABS).  A standard NMR line-broadening 
factor of 30 Hz was applied in the frequency domain.  The U-ATP peaks were calibrated 
to 7.5 ppm to match traditional 31P NMR data presentation. By utilizing the Bruker’s 
integration function, the area under each of the five peaks was determined. Individual 
phosphate levels in each spectrum were determined as a percentage of the total phosphate 
peak area for PCr, Pi, U/;/V ATP, and phosphomonoesters (PME).  Figure 4.3 are spectra 
from Run #1 during pre-ischemia, ischemia, and reperfusion. 
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Fig 4.3. Representative 31P NMR spectra from Run #1. Each spectrum shows five peaks and assigned as 
follows (from left): phosphomonoesters and inorganic phosphate (PME+Pi), phosphocreatine (PCr), 8-
adenosine triphosphate (ATP), 9-ATP, and :-ATP. (A) Control, pre-ischemia; (B) Two minutes into  
ischemia; (C) 10 minutes into ischemia; (D) 24 minutes after reperfusion. 
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4.4 Time Course of Phosphates and Intracellular pH
Individual phosphate levels in each spectrum were determined as a percentage of 
the total phosphate peak area for PCr, Pi, U/;/V ATP, and phosphomonoesters (PME).  
Figure 4.4 shows analysis of phosphate levels before, during, and after ischemia for Run 
#1 and Run #2.  In Run #1, acute ischemia was induced for 10 minutes while in Run #2, 
ischemia was induced for 20 minutes.  Run #2 also provided a longer reperfusion period 
that seems to provide a more complete view of recovery.  
The data conforms to previous findings concerning the stoichiometric relationship 
between inorganic phosphate and phosphocreatine; as phosphocreatine levels decrease, 
inorganic phosphate levels increase (Honda, Hajime et. al. 2002). Also as expected, ;-
ATP levels appear to decrease slightly during ischemia; however this decrease is small 
relative to changes in phosphocreatine and inorganic phosphate levels.  In Run #2, 
reperfusion phosphate levels almost return to their pre-ischemia values. However, even 
after reperfusion, NMR data from Run #1 suggests the heart remains ischemic. 
In Run #1, the difference between PCr levels at the pre-ischemia baseline and 
levels shortly before reperfusion is approximately 19% TP. Following the same process, 
the maximum change in Pi levels and ;-ATP levels is approximately 20% TP and 4% TP, 
respectively.  In Run #2, the maximum change in PCr, Pi, and ;-ATP levels is 
approximately 19% TP, 35 %TP, and 3% TP, respectively.  
Figure 4.5 shows the time course of pH levels during Run #1 and Run #2.  The 
intracellular pH was determined by comparing the Pi chemical shift in each spectrum 
with the Pi chemical shift from a standard solution (Seo, Murakami et. al. 1983).  Run #1 
shows a decrease in pH from W 7.1 to 6.8.  Run #2 appears to have no change in pH. 
 
25
Fig 4.4. Complete time course of changes in 9-ATP, PCr, and Pi levels during (A) Run #1 and (B) Run #2. 
Ischemia was induced by turning off the perfusion apparatus at the 20-minute mark. Reperfusion of the 
rabbit heart occurred at the 30-minute mark in Run #1 and at the 40-minute mark in Run #2. 
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Fig 4.5. Complete time course of changes in intracellular pH during (A) Run #1 and (B) Run #2. 
 
CHAPTER V 
 
DISCUSSION 
 
5.1Explanations for Abnormal Optical AP Morphology
There were two main concerns after analyzing the optical AP data in Run #2: (1) 
the prolonged action potential duration and (2) the lack of an obvious phase-zero 
depolarization.  There are several explanations for the prolonged action potential 
duration.  First, temperature can have a significant effect on AP characteristics.  For 
example, decreased temperatures ranging from approximately 15–21°C can result in a 
heart rate of as little as a few BPM.  Temperature affects the permeability of the cardiac 
myocyte membrane to the ions that are responsible for excitation.  Higher temperatures 
provide increased permeability (i.e. rates at which channels open, close, and inactivate) 
and a higher level of excitability (Guyton, A. C. et. al. 2000).  It is also a well-known fact 
that chemical reactions, i.e. metabolic processes, proceed at a faster rate with warmer 
temperatures. Considering all experiments were performed at a room temperature of 
approximately 23.5°C, it is expected that APD would increase due to slower changes in 
ionic currents.  Therefore, the phase-zero depolarization, plateau, repolarization, etc. 
would all be prolonged.  Kiyosue et. al. studied action potential prolongation at low 
temperatures in guinea-pig ventricular myocytes.  They found that by reducing the 
temperature from 33-34°C to 24-25°C the APD increased by 115% (Kiyosue T. et. al. 
28
1993).  Knisley et. al. recorded normal optical APs at 35-36°C that were approximately 
200 ms in duration with a setup similar to the one in this thesis (Knisley, S.B. et. al. 
2000).  Therefore, considering Run #1 produced AP recordings approximately 2 seconds 
in duration at 11°C colder, there seems to be other factors possibly involved in 
prolonging APD.  Also, recall the conclusion that, during ischemia, AP duration is first 
prolonged and then shortens (Verkerk, Arie O., Veldkamp, Marieke W., et al. 1996).  If 
temperature slows metabolic processes and the rate at which channels open, close, and 
inactivate, then 23.5°C might have been cold enough that AP duration had not yet 
reached the point where it begins to shorten. Therefore, low temperature might explain 
the fact that Run #2 had APs that continued to increase in duration.   
 Spatial averaging is another concept that might have influenced the apparent 
APD.  When recording optical APs, our fiber optic’s open end is placed firmly against 
the base of the ventricular endocardium.  Girouard, S.D. et. al. introduced the idea that 
poor spatial resolution due to larger recording site areas can prolong the upstroke of an 
AP.  They concluded that since the optical AP is derived from the average of all the 
single cell potentials in the volume under interrogation, it is possible that artifactual 
prolongation of the AP can skew recordings (Girouard, S.D. et. al. 1996).   
Three other possibilities exist for prolonged APD.  First, air bubbles might have 
been introduced into the coronary vessels during perfusion causing air emboli and local 
areas of ischemia before perfusion was terminated.  Second, ischemia could have also 
been a result of damage to the heart during or after surgery.  Prolonged periods without 
perfusion or low perfusate temperatures could have sent the heart into premature 
ischemia.  Third, the optical signal contained both transmembrane APs and motion 
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artifacts due to the chance in geometry when the heart contracts.  Contraction may be 
slow when hearts are ischemic or cool, producing a large APD. 
As for the apparent absence of phase-zero depolarization in the optical APs of 
Run #2, only two explanations are offered.  First, the position of the fiber tip could have 
been altered by the movement of the heart during contraction.  If the tip of the fiber optic 
lost contact with the left ventricular endocardium, there would be increased spatial 
averaging, increased motion artifacts, and changes in the green and red signal due to 
transmittance across air and perfusate.  Second, extremely poor spatial resolution of the 
fiber optic could have distorted the phase-zero depolarization beyond recognition.   
5.2 Viability of AP Recordings
In order to convincingly correlate the optical AP data with the NMR data, the 
viability of the optical AP recordings must be confirmed.  Run #2 produced APDs that 
were more similar to expected values, but lacked the standard, characteristic AP 
morphology seen in Run #1’s control recording.  It can be argued that the optical AP 
recordings for Run #2 are viable based on two points: (1) even with abnormal 
characteristics, the optical recordings in Run #2 consistently follow the trends expected 
for AP morphology during ischemia; (2) and possibly the most compelling argument, raw 
oscilloscope measurements show electrical activity in the green and red recordings.  Run 
#2 produced APDs that were more feasible, but unfortunately lacked the standard, 
characteristic AP morphology seen in Run #1’s control recording. 
The analysis of the characteristics of the optical AP recordings for Run #2 follows 
trends for previous findings concerning changes in AP morphology during ischemia.  The 
APA decreases from 0.3 at the onset of ischemia to 0.05 before reperfusion (Hicks, M. N. 
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et. al. 1995).  However, APD50% shows an increase from 0.25 sec to at least 2 sec. 
Previous findings observed a short period of APD prolongation followed by APD 
shortening (Verkerk, Arie O., Veldkamp, Marieke W., et al. 1996).  However, previously 
discussed low temperature concerns combined with ischemic conditions may have 
prolonged the period of APD prolongation.  Also, delayed motion in ischemia may 
prolong the signal.  Considering BPM data were calculated from the APD50%, the 
intrinsic heart rate appeared to decrease at least by 25.47 BPM. After approximately 15 
minutes of reperfusion, APs showed a near full recovery of APA, APD50%, and BPM as 
expected in acute ischemia.  
Figure 5.1 shows raw oscilloscope measurements from the green PMT and red 
PMT.  The presence of electrical activity can be verified by searching for points where 
one signal is increasing in magnitude while the other signal is simultaneously decreasing, 
indicated by the red lines in the examples below.  Run #2 confirms electrical activity; 
however possible malfunction in the PMT unit or unknown factors seem to have inverted 
or concealed it. 
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Figure 5.1.  Fluorescence emission recordings for (A) Run #1 (pre-ischemia) and (B) Run #2 (approx. 4 
min into ischemia).  Red lines indicate phase-zero depolarization.  
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5.3 Simultaneous 31P NMR and Optical Recordings of APs
During acute ischemia, several changes occur related to electrical activity and 
metabolism in the heart.  As APA decreased and APD increased, PCr levels decreased 
and Pi levels increased.  ;-ATP levels slightly decreased as well, but the consumption of 
PCr stores and stimulation of the glycolytic pathway keep ATP levels relatively constant.  
(However, prolonged ischemia will eventually exhaust ATP stores.)   
ATP consumption may have also indirectly prolonged the APD further. The 
production of free radicals is a normal by-product of ATP consumption.  However, 
during ischemia, free radicals accumulate, along with lactic acid and Pi, because of the 
cardiac muscle’s inability to eliminate them efficiently.  Free radicals attack proteins and 
lipids, therefore, excessive amounts of free radicals can cause disturbances in ion 
permeation and the behavior of membrane channels (Carmeliet, Edward 1999).  During 
acute ischemia, accumulated oxygen-derived free radicals increase APD by inhibiting 
resting K+ leakage current and possibly altering the time-dependent currents of voltage-
gated K+ and Ca2+ channels (Jabr, R. I. and Cole, W. C. 1993).   
During reperfusion, APA and APD returned almost to control levels.  This 
coincided with the return of PCr and Pi to control levels as well.  ;-ATP levels recovered 
slower, as expected with longer periods of ischemia (Carmeliet, Edward 1999).  
 Run #1 appeared to have a decrease in pH levels over the course of the 
experiment.  However, Run #2 had no apparent change in pH levels.  This may be due to 
the ability of the heart from Run #2 to recover during reperfusion.  Based upon the fact 
that PCr and Pi levels never returned to their original levels, it can be assumed that the 
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heart from Run #1 remained ischemic through reperfusion.  Therefore, changes in pH 
might be more pronounced during longer periods of ischemia. 
 
CHAPTER IV 
 
CONCLUSIONS 
 
Using the dual modality system, it was possible to simultaneously recorded 
cardiac optical APs and high-energy metabolite levels.  Energy levels changed as 
expected while fluorescence showed decrease in heart rate and other characteristics of 
ischemia.  For the first time to our knowledge, cardiac optical APs and high-energy 
metabolite levels are able to be recorded simultaneously and analyzed for correlation, 
providing a wealth of new insight into the relationship between cardiac metabolism and 
electrical activity. 
Since fabrication, the system has been further optimized for improved 
performance.  One of the goals of the current research was to improve upon the system 
even more, utilizing current results.  Therefore, there are several improvements for future 
work.  First, the heart temperature will be regulated and monitored during each 
experiment to ensure hearts remain at normal, physiological temperature.  Second, the 
fiber optic tip will be properly secured against the left ventricular endocardium to resolve 
any issues with loss of contact.  Third, the proper spatial area of the fiber optic tip will be 
determined for maximum spatial resolution.  Fourth, the temporal resolution will be 
reduced further to attempt to observe faster changes in AP morphology and high-energy 
metabolite levels.  Improving upon this system will provide future researchers with a 
powerful tool for correlating changes in cardiac electrical activity with metabolism. 
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